Cerulea Clinical Trials

Close Menu
Close Close

Science and Research

iSight2 (iLumen)

Microcurrent stimulation therapy for intermediate to advanced nonexudative age-related macular degeneration (i-SIGHT2): a multicentre, randomised, sham-controlled, double-masked, clinical device trial.

Overview

Microcurrent stimulation therapy for intermediate to advanced nonexudative age-related macular degeneration (i-SIGHT2): a multicentre, randomised, sham-controlled, double-masked, clinical device trial.

  • Principal Investigator
Professor Robyn Guymer AM

Learn more

View this study at ClinicalTrials.gov

This database listing provides more detailed information about this study.

Read More

Related Pages

Clinical Trials

Register a patient

We welcome healthcare practitioners to register interested patients who may be suitable for a clinical trial at Cerulea.

Clinical Trials

Register your interest in clincal trials

To express interest in taking part in current or future clinical trials at Cerulea, please join our online database. First, here are some important things you need to know.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.